Literature DB >> 8136056

Nucleus basalis magnocellularis and attention: effects of muscimol infusions.

K Pang1, M J Williams, H Egeth, D S Olton.   

Abstract

The basal forebrain is important in cognitive processing. Most studies have focused on the importance of this area in mnemonic processing. However, the nucleus basalis magnocellularis (NBM), which is a major component of the basal forebrain, may also be involved in attentional processes. Attention can influence the sensitivity of perceptual processes, as assessed by discriminability, or the selection of response strategies, as assessed by bias. This experiment examined whether temporary inactivation of the NBM, using the GABA agonist muscimol, would interfere with attention. Each rat was tested in a 2-choice reaction time (RT) task in which stimulus frequency was varied. RT and error rate increased, and discriminability decreased following muscimol infusions into the NBM. Bias was unchanged. The pattern of results provides evidence that the NBM is important in attention, and this influence of the NBM acts primarily on perceptual aspects of attention.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8136056     DOI: 10.1037//0735-7044.107.6.1031

Source DB:  PubMed          Journal:  Behav Neurosci        ISSN: 0735-7044            Impact factor:   1.912


  13 in total

1.  Hyperactivity and learning deficits in transgenic mice bearing a human mutant thyroid hormone beta1 receptor gene.

Authors:  M P McDonald; R Wong; G Goldstein; B Weintraub; S Y Cheng; J N Crawley
Journal:  Learn Mem       Date:  1998 Sep-Oct       Impact factor: 2.460

2.  Basal forebrain dynamics during a tactile discrimination task.

Authors:  Eric Thomson; Jason Lou; Kathryn Sylvester; Annie McDonough; Stefani Tica; Miguel A Nicolelis
Journal:  J Neurophysiol       Date:  2014-06-11       Impact factor: 2.714

3.  Lesions of the amygdala central nucleus alter performance on a selective attention task.

Authors:  P C Holland; J S Han; M Gallagher
Journal:  J Neurosci       Date:  2000-09-01       Impact factor: 6.167

4.  Effects of a novel CB1 agonist on visual attention in male rats: role of strategy and expectancy in task accuracy.

Authors:  Rikki L A Miller; Ganesh A Thakur; William N Stewart; Joshua P Bow; Shama Bajaj; Alexandros Makriyannis; Peter J McLaughlin
Journal:  Exp Clin Psychopharmacol       Date:  2013-10       Impact factor: 3.157

5.  Neuronal ensemble bursting in the basal forebrain encodes salience irrespective of valence.

Authors:  Shih-Chieh Lin; Miguel A L Nicolelis
Journal:  Neuron       Date:  2008-07-10       Impact factor: 17.173

6.  Identification and distribution of projections from monoaminergic and cholinergic nuclei to functionally differentiated subregions of prefrontal cortex.

Authors:  Daniel J Chandler; Carolyn S Lamperski; Barry D Waterhouse
Journal:  Brain Res       Date:  2013-05-07       Impact factor: 3.252

7.  Wistar-Kyoto rats as an animal model of anxiety vulnerability: support for a hypervigilance hypothesis.

Authors:  J D McAuley; A L Stewart; E S Webber; H C Cromwell; R J Servatius; K C H Pang
Journal:  Behav Brain Res       Date:  2009-06-11       Impact factor: 3.332

8.  Dissociation between the attentional effects of infusions of a benzodiazepine receptor agonist and an inverse agonist into the basal forebrain.

Authors:  L A Holley; J Turchi; C Apple; M Sarter
Journal:  Psychopharmacology (Berl)       Date:  1995-07       Impact factor: 4.530

9.  Evidence for broad versus segregated projections from cholinergic and noradrenergic nuclei to functionally and anatomically discrete subregions of prefrontal cortex.

Authors:  Daniel Chandler; Barry D Waterhouse
Journal:  Front Behav Neurosci       Date:  2012-05-21       Impact factor: 3.558

Review 10.  Nicotinic acetylcholine receptors in attention circuitry: the role of layer VI neurons of prefrontal cortex.

Authors:  Eliane Proulx; Matthew Piva; Michael K Tian; Craig D C Bailey; Evelyn K Lambe
Journal:  Cell Mol Life Sci       Date:  2014-04       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.